New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Published Jun 18, 2020

New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer

Checkpoint inhibitor OPDIVO has shown tremendous promise for patients battling advanced esophageal cancer. An expert tells SurvivorNet that in esophageal cancer, anything that improves survival in patients whose disease already progresses after chemotherapy is remarkable.

NOW
PLAYING
Dick Vitale Working During Chemo Shows Strides In Elderly Cancer Care
NOW
PLAYING
What You Need to Know About Cisplatin Chemotherapy Treatment for Advanced-Stage Bladder Cancer
NOW
PLAYING
How is Bladder Cancer Treated Differently Once it Has Spread Beyond the Bladder?
NOW
PLAYING
Dancer Criscilla Anderson, 41, Needs Healing After Her Joyful 'NED' News from Stage 4 Colon Cancer: 'I Do Not Want To Be Reminded That I Have Cancer'
NOW
PLAYING
ENHERTU Is A 'Big Game Changer' for HER2 Positive Metastatic Breast Cancer Patients
NOW
PLAYING
New Hope for Patients With Cervical Cancer: Adding Immunotherapy Drug to Standard Chemo Treatment Could Improve Survival Time

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.